Percent of total cells that stain strongly for CD163
| Specimen | CD163 Level |
|---|---|
| Benign parotid lymph node 1 | 4.79% |
| Benign parotid lymph node 2 | 13.61% |
| Benign parotid lymph node 3 | 37.84% |
| Benign parotid lymph node 4 | 10.08% |
| Benign parotid lymph node 5 | 10.01% |
| Benign parotid lymph node 6 | 26.93% |
| Benign parotid lymph node 7 | 18.84% |
| Benign parotid lymph node 8 | 12.84% |
| Benign parotid lymph node 9 | 23.33% |
| Benign parotid lymph node 10 | 29.16% |
| Benign parotid lymph node 11 | 14.78% |
| Benign parotid lymph node 12 | 8.52% |
| Average benign parotid lymph node | 17.56% |
| Negative draining lymph node | 62.94% |
| Lymph node with metastatic focus of prostate adenocarcinoma | 42.91% |
| Primary tumor | 50.46% |